MCO
CLPT icon

MAK Capital One’s ClearPoint Neuro CLPT Stock Holding History

MAK Capital One’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.4M Buy
2,375,861
+474,372
+25% +$5.93M 5.94% 7
2026
Q1 		$17.3M Buy
+1,901,489
New +$24M 2.55% 12

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

MAK Capital One's CLPT Position: Q2 2026 in Review

MAK Capital One increased its ClearPoint Neuro (CLPT) stake by 25% in Q2 2026, buying an estimated $5.93M and bringing the position to 2,375,861 shares worth $42.4M. The position accounts for 5.94% of the portfolio, ranked #7.

MAK Capital One first reported a position in CLPT in Q1 2026 and has held it in 2 quarters since. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • MAK Capital One held 2,375,861 shares of ClearPoint Neuro worth $42.4M as of Q2 2026.
  • MAK Capital One bought 474,372 ClearPoint Neuro shares in Q2 2026, an estimated $5.93M.
  • ClearPoint Neuro made up 5.94% of MAK Capital One's portfolio in Q2 2026, its #7 holding.
  • MAK Capital One first reported a position in ClearPoint Neuro in Q1 2026 and has held it in 2 quarters since.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on MAK Capital One's 13F filing for Q2 2026, filed 14 Aug 2026.